S&P 500 Gains and Losses Today: Moderna Plunges After Big Cut to Sales Forecast
1. Moderna lowered 2025 revenue guidance by $1 billion, impacting investor confidence. 2. Shares plummeted 16.8% after announcing cost cuts totaling $1.5 billion. 3. Revenue is expected to rely on COVID-19 and RSV vaccines in second half.